Another case of t(17;22)(q22;q13) in an infantile dermatofibrosarcoma protuberans - PubMed

Case Reports

Another case of t(17;22)(q22;q13) in an infantile dermatofibrosarcoma protuberans

F Pedeutour et al. Cancer Genet Cytogenet. 1996.

Abstract

We have identified a new dermatofibrosarcoma protuberans (DP) case with a t(17;22) (q22;q13) occurring in a child. The translocation was substantiated by the presence of one or two copies of the sole der(22)t(17;22). This rearrangement added to two normal chromosomes 17 and one or two chromosomes 22, resulted in trisomy 22cen-q13 and trisomy (or tetrasomy) 17q22-25. This observation confirms the specificity of the association of DP with the t(17;22) found together with extra copies of the der(22)t(17;22). It also points out a possible prevalence of translocation rather than rings in DP of the childhood disease.

Similar articles

• Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement.

  Pedeutour F, Simon MP, Minoletti F, Barcelo G, Terrier-Lacombe MJ, Combemale P, Sozzi G, Ayraud N, Turc-Carel C. Pedeutour F, et al. Cytogenet Cell Genet. 1996;72(2-3):171-4. doi: 10.1159/000134178. Cytogenet Cell Genet. 1996. PMID: 8978765

• Translocation (17;22)(q22;q13) in a case of subcutaneous dermatofibrosarcoma protuberans in an adult.

  Dobin SM, Diaz JA, Silva MT, Truss LM, Donner LR. Dobin SM, et al. Cancer Genet Cytogenet. 1999 Feb;109(1):86-7. doi: 10.1016/s0165-4608(98)00147-2. Cancer Genet Cytogenet. 1999. PMID: 9973968 No abstract available.

• Spectral karyotyping reveals 17;22 fusions in a cytogenetically atypical dermatofibrosarcoma protuberans with a large marker chromosome as a sole abnormality.

  Mrózek K, Iliszko M, Ryś J, Babińska M, Niezabitowski A, Bloomfield CD, Limon J. Mrózek K, et al. Genes Chromosomes Cancer. 2001 Jun;31(2):182-6. doi: 10.1002/gcc.1131. Genes Chromosomes Cancer. 2001. PMID: 11319805

• [Molecular genetics of dermatofibrosarcoma protuberans: an update].

  Zhou XL, Fan QH. Zhou XL, et al. Zhonghua Bing Li Xue Za Zhi. 2006 Jan;35(1):44-7. Zhonghua Bing Li Xue Za Zhi. 2006. PMID: 16608650 Review. Chinese. No abstract available.

• Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberans.

  Minoletti F, Miozzo M, Pedeutour F, Sard L, Pilotti S, Azzarelli A, Turc-Carel C, Pierotti MA, Sozzi G. Minoletti F, et al. Genes Chromosomes Cancer. 1995 May;13(1):62-5. doi: 10.1002/gcc.2870130110. Genes Chromosomes Cancer. 1995. PMID: 7541645 Review.

Cited by

• Dermatofibrosarcoma Protuberans-Like Tumor With COL1A1 Copy Number Gain in the Absence of t(17;22).

  Saab J, Rosenthal IM, Wang L, Busam KJ, Nehal KS, Dickson MA, Hameed MR, Hollmann TJ. Saab J, et al. Am J Dermatopathol. 2017 Apr;39(4):304-309. doi: 10.1097/DAD.0000000000000746. Am J Dermatopathol. 2017. PMID: 27984233 Free PMC article.

• Imatinib in the treatment of dermatofibrosarcoma protuberans.

  Labropoulos SV, Razis ED. Labropoulos SV, et al. Biologics. 2007 Dec;1(4):347-53. Biologics. 2007. PMID: 19707305 Free PMC article.

• Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

  Rutkowski P, Van Glabbeke M, Rankin CJ, Ruka W, Rubin BP, Debiec-Rychter M, Lazar A, Gelderblom H, Sciot R, Lopez-Terrada D, Hohenberger P, van Oosterom AT, Schuetze SM; European Organisation for Research and Treatment of Cancer Soft Tissue/Bone Sarcoma Group; Southwest Oncology Group. Rutkowski P, et al. J Clin Oncol. 2010 Apr 1;28(10):1772-9. doi: 10.1200/JCO.2009.25.7899. Epub 2010 Mar 1. J Clin Oncol. 2010. PMID: 20194851 Free PMC article.

• Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans.

  Rutkowski P, Wozniak A, Switaj T. Rutkowski P, et al. Sarcoma. 2011;2011:959132. doi: 10.1155/2011/959132. Epub 2011 Mar 30. Sarcoma. 2011. PMID: 21559214 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information